Page last updated: 2024-10-23

bisindolylmaleimide i and Seizures

bisindolylmaleimide i has been researched along with Seizures in 1 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.

Research Excerpts

ExcerptRelevanceReference
" In the presence of 8-cyclopentyl-1,3-dimethylxanthine (CPT), an adenosine A(1) receptor antagonist, the occurrence of spontaneous seizure activity was greatly increased as was the duration and intensity of evoked seizures, whilst the postictal depression of basal synaptic transmission was greatly attenuated."3.72Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner. ( Etherington, LA; Frenguelli, BG, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Etherington, LA1
Frenguelli, BG1

Other Studies

1 other study available for bisindolylmaleimide i and Seizures

ArticleYear
Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner.
    The European journal of neuroscience, 2004, Volume: 19, Issue:9

    Topics: Adenosine; Animals; Animals, Newborn; Dihydropyridines; Dose-Response Relationship, Drug; Drug Inter

2004